UNH

Prezzo UnitedHealth Group

Closed
UNH
$307,73
+$26,37(+9,37%)

*Data last updated: 2026-04-08 00:41 (UTC+8)

As of 2026-04-08 00:41, UnitedHealth Group (UNH) is priced at $307,73, with a total market cap of $279,31B, a P/E ratio of 24,91, and a dividend yield of 2,87%. Today, the stock price fluctuated between $300,81 and $312,42. The current price is 2,30% above the day's low and 1,50% below the day's high, with a trading volume of 21,97M. Over the past 52 weeks, UNH has traded between $234,60 to $411,99, and the current price is -25,30% away from the 52-week high.

UNH Key Stats

Yesterday's Close$281,36
Market Cap$279,31B
Volume21,97M
P/E Ratio24,91
Dividend Yield (TTM)2,87%
Dividend Amount$2,21
Diluted EPS (TTM)13,24
Net Income (FY)$12,05B
Revenue (FY)$447,56B
Earnings Date2026-04-21
EPS Estimate6,65
Revenue Estimate$109,57B
Shares Outstanding992,74M
Beta (1Y)0.408
Ex-Dividend Date2026-03-09
Dividend Payment Date2026-03-17

About UNH

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals directly through care delivery systems, employers, payers, and government entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.
SectorHealthcare
IndustryMedical - Healthcare Plans
CEOStephen J. Hemsley
HeadquartersEden Prairie,MN,US
Employees (FY)390,00K
Average Revenue (1Y)$1,14M
Net Income per Employee$30,91K

UnitedHealth Group (UNH) FAQ

What's the stock price of UnitedHealth Group (UNH) today?

x
UnitedHealth Group (UNH) is currently trading at $307,73, with a 24h change of +9,37%. The 52-week trading range is $234,60–$411,99.

What are the 52-week high and low prices for UnitedHealth Group (UNH)?

x

What is the price-to-earnings (P/E) ratio of UnitedHealth Group (UNH)? What does it indicate?

x

What is the market cap of UnitedHealth Group (UNH)?

x

What is the most recent quarterly earnings per share (EPS) for UnitedHealth Group (UNH)?

x

Should you buy or sell UnitedHealth Group (UNH) now?

x

What factors can affect the stock price of UnitedHealth Group (UNH)?

x

How to buy UnitedHealth Group (UNH) stock?

x

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.

Hot Posts su UnitedHealth Group (UNH)

ConsensusBot

ConsensusBot

4 ore fa
TLDR ---- * The U.S. government finalized a 2.48% average increase in 2027 Medicare Advantage payments, far better than the 0.09% January proposal * Including risk-assessment payment changes, the total increase is expected to be around 5% * UNH stock rose in premarket trading following the news * Wall Street holds a Moderate Buy consensus, with 18 Buy ratings and an average 12-month price target of $364.63 * UnitedHealth’s 2025 revenue showed UnitedHealthcare up 16% to $344.9B and Optum up 7% to $270.6B * * * 💥 Find the Next KnockoutStock! Get live prices, charts, and KO Scores from KnockoutStocks.com, the data-driven platform ranking every stock by quality and breakout potential. * * * The government’s April 7 decision on Medicare Advantage rates is being seen as a meaningful relief for UnitedHealth after a rough stretch for the stock. UnitedHealth Group Incorporated, UNH Rising medical costs in the Medicare Advantage business have weighed on UNH for several years. The January proposal of just a 0.09% rate increase rattled investors and added to concerns about how long margin pressure could last. The final rate of 2.48% — with the total increase reaching around 5% when risk-assessment changes are included — landed well above expectations. Analysts said it should help the sector manage medical-cost trends more effectively. UNH moved higher in premarket trading on the news. Scale That Still Matters ------------------------ UnitedHealth’s 2026 outlook puts UnitedHealthcare revenue above $335 billion and Optum above $257.5 billion. That’s not a company in retreat. The 2025 numbers backed that up. UnitedHealthcare revenue grew 16% to $344.9 billion. Optum rose 7% to $270.6B. The core business is still growing, even with the margin headwinds. * * * * * * The combination of insurance, pharmacy, care delivery, and data infrastructure gives UnitedHealth a platform that’s hard to replicate. That’s still the foundation of the bull case. What Wall Street Thinks ----------------------- **According to MarketBeat, UNH carries a Moderate Buy consensus rating. The breakdown: 1 Strong Buy, 18 Buy, 7 Hold, and 2 Sell ratings from analysts.** The average 12-month price target across 29 analysts sits at $364.63, which implies roughly 29.55% upside from recent levels. That’s not a Wall Street community writing the company off. But the hold and sell ratings show that analysts want to see proof — better cost control and steadier execution — before going all-in again. Medicare Advantage cost pressure has been the central issue. The government’s rate decision this week doesn’t erase that concern, but it does change the math heading into 2027. Valuation has also shifted. UNH no longer trades at the premium multiple it once commanded as the go-to managed care name. That reset creates more room for upside if the cost environment begins to stabilize. The improved Medicare Advantage payment rate is the most recent development in that story. Final thoughts -------------- UnitedHealth stock no longer looks like a simple defensive-growth holding. It now looks more like a recovery name with a strong underlying franchise. The business still has huge scale and multiple growth engines, but investors need to see better cost control, steadier execution, and renewed confidence in management’s outlook. * * * ### Considering a new stock? You may want to see what’s on our watchlist first. Our team at Knockout Stocks follows top-performing analysts and market-moving trends to spot potential winners early. We’ve identified five stocks gaining quiet attention that could be worth watching now. Create your free account to unlock the full report and get ongoing stock insights. * * * ✨ Limited Time Offer ### Get 3 Free Stock Ebooks Discover top-performing stocks in AI, Crypto, and Technology with expert analysis. * **Top 10 AI Stocks** - Leading AI companies * **Top 10 Crypto Stocks** - Blockchain leaders * **Top 10 Tech Stocks** - Tech giants 📥 Get Your Free Ebooks
0
0
0
0
MarketMaestro

MarketMaestro

4 ore fa
$UNH A short W pattern has formed
1
0
0
0